TrialInvestigational new drugs2021

Phase 2 study of TAS-117, an allosteric akt inhibitor in advanced solid tumors harboring phosphatidylinositol 3-kinase/v-akt murine thymoma viral oncogene homolog gene mutations.

Jii Bum Lee et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.